Kintsugi
PrivateLast Round
Series A
Feb 23, 2022
Total Funding Raised
$28.63M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Kintsugi operates in Healthcare & Life Sciences and is based in Berkeley, California. Its latest recorded funding round was a Series A round in February 2022.
Kintsugi is a healthcare technology company that develops voice biomarker infrastructure to detect signs of clinical depression and anxiety from short clips of free-form speech.
Sector
Healthcare & Life Sciences
Verticals
Mental Health, Medical AI, NLP & Conversational AI, Healthcare Analytics
Business Model
B2B2C
Customer Profile
Usage-Based SaaS, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kintsugi Comparables
Compare Kintsugi with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Canary Speech | 89% | |
| Ellipsis Health | 89% | |
| Sonde Health | 86% |
For institutional investors. Book with your work email.
Kintsugi Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 23, 2022 | ||||
| Seed | Aug 26, 2021 | ||||
| Accelerator | Aug 31, 2020 | ||||
| Grant | Jul 1, 2020 | ||||
| Grant | Oct 15, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Kintsugi Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| IT-Farm Corporation | Series A, Seed |
| Headwater Ventures | Seed |
| Techstars | Seed, Accelerator |
| Side Door Ventures | Series A |
| Acrew Capital | Series A, Seed |
| Citta Capital | Series A, Seed |
| Primetime Partners | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 43% MoM, reaching 7.9K.
- Mar 27, 2025
Haritha joins from Apple, where she managed SaMD clinical trials.
For institutional investors. Book with your work email.
Kintsugi Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Kintsugi's valuation, stock price, and market status.
Is Kintsugi a public or private company?
Kintsugi is a private company.
What is the current stock price of Kintsugi?
Kintsugi is a private company, so its shares have no public market price. Caplight tracks Kintsugi's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Kintsugi worth (valuation)?
Valuation information for Kintsugi is not publicly available.
Can I buy Kintsugi stock?
Kintsugi shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Kintsugi's last funding round?
Kintsugi's most recent funding round was Series A on February 23, 2022.
Who are the main investors in Kintsugi?
Key investors in Kintsugi include Acrew Capital, Insight Partners.
Will Kintsugi IPO soon?
No public IPO plans have been announced for Kintsugi.
How can I track Kintsugi secondary market activity?
Caplight tracks bids, offers, and trades in Kintsugi's shares on secondary markets.